Formulation & Forced Degradation Strategies for Biomolecules

Online Registration is open!

Have a question about this event?
Customer Service representatives are available to help from 8 AM - 6 PM EST
Call 888-670-8200

Need Technical Assistance With this Website?
Send an email to IIR's Web Department

Invite a colleague to join you at this event

Send to Friend

Save the event dates in your Outlook calendar

Add to Outlook Diary

Advanced Search

Home»Events»Formulation & Forced...Event Overview»Agenda Day Two

Formulation & Forced Degradation Strategies for Biomolecules

The only conference tying analytics into formulation
considerations and delivery techniques!

March 19 - 21, 2007 | Hilton San Diego Mission Valley, | San Diego, CA

Agenda Day Two

Wednesday, March 21st, 2007

This is just a snapshot of the FFD Agenda Day Two.
For full details please download our brochure.

8:00 | Morning Coffee

8:45 | Co-Chairperson's Welcome & Recap of Day One

Jerry J. Lewis, MBA., PhD
Senior Research Advisor,
ELI LILLY AND COMPANY

Vu Truong-Le, PhD
VP of Research and Development,
ARIDIS PHARMA

9:00	Aggregation as a Result of Forced Degradation – What Do You Do? Wei Wang, PhD, Associate Research Fellow, PFIZER
9:30	Case Study! Generation, Identification and Prevention of Aggregate Formation During Controlled Freeze-Thaw David Sek, Scientist II, WYETH BIOPHARMA
10:00	30 Minute Networking and Refreshment Break
10:30	Case Study! Strategies and Limitations of High Throughput Biomolecule Formulation Screening Wm. Randy Forsyth, PhD, Sr. Scientist, Emerging Sciences & Technology, TRANSFORM PHARMACEUTICALS
11:15	Optimizing Protein Pharmaceutical Formulations with the Use of Second Virial Coefficients Measurements Larry J. DeLucas, OD, PhD, DSc. (hon.), Professor and Director of the Center for Biophysical Sciences and Engineering, THE UNIVERSITY OF ALABAMA AT BIRMINGHAM
12:00	Networking Luncheon
Your Choice of Afternoon Tracks: Please feel free to mix and match sessions to individualize your learning experience!
	Track C: Drug Delivery and Formulation	Track D: Degradant Analysis
1:30	Case Study Optimize Peptide Formulation for Delivery Kurshid Iqbal, PhD, Senior VP and CSO, KBI BIOPHARMA, INC	Identify and Analyze Degradants using Mass Spectrometry Nelly Viseux, PhD, Sr. Research Scientist, Biotech Analytics, BAXTER HEALTHCARE
2:00	Implement Formulation Adjustments when Working with Inhalables or Injectables OPEN SESSION! If you are interested in speaking/sponsoring opportunities, please contact Tricia Carle at TCarle@iirusa.com	Applying Analytical Ultracentrifugation to Force Degraded Biomolecules Charles Morgan PhD, Senior Scientist, Therapeutic Protein Research, GENZYME CORPORATION
2:30	15 Minute Networking and Refreshment Break
2:45	Selecting and Managing a Platform Technology Partner for the Sustained Released of Biomolecules Warren Jaworowicz, Sr. Scientist, STRYKER BIOTECH	Case Study! Experience with Different Aggregation Data from SEC vs. other Biophysical Techniques in a Regulatory Application for a Peptide Therapeutic Jerry J. Lewis, MBA., PhD, Senior Research Advisor, ELI LILLY AND COMPANY
3:15	Q & A: Formulation Considerations for Alternate Delivery Mechanisms Moderator: Tiansheng Li, PhD, Senior Principal Scientist, Department of Pharmaceutics, AMGEN Panelists: Warren Jaworowicz, Sustained Release, STRYKER BIOTECH Kurshid Iqbal, Senior VP of Drug Delivery, KBI BIOPHARMA Vince Sullivan, Group Leader, ADD, Formulations, BD TECHNOLOGIES	Q & A on Best Analytical Techniques Moderator: Jerry J. Lewis, MBA., PhD, Senior Research Advisor, ELI LILLY AND COMPANY Panelists: Anna-Maria Hays Putnam, PhD, Research Scientist II, Analytical and Formulations Development, AMBRX Nelly Viseux, PhD, Sr. Research Scientist, Biotech Analytics, BAXTER HEALTHCARE Charles Morgan PhD, Senior Scientist, Therapeutic Protein Research, GENZYME CORPORATION
4:00	Conference Concludes